PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
48.13%
Revenue growth at 50-75% of FSLR's 74.39%. Martin Whitman would worry about competitiveness or product relevance.
268.96%
Gross profit growth above 1.5x FSLR's 163.14%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
22.43%
EBIT growth below 50% of FSLR's 1386.14%. Michael Burry would suspect deeper competitive or cost structure issues.
7.68%
Operating income growth under 50% of FSLR's 1386.14%. Michael Burry would be concerned about deeper cost or sales issues.
42.14%
Net income growth under 50% of FSLR's 295.95%. Michael Burry would suspect the firm is falling well behind a key competitor.
41.79%
EPS growth under 50% of FSLR's 294.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
41.79%
Diluted EPS growth under 50% of FSLR's 290.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.05%
Share count expansion well above FSLR's 0.09%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.05%
Diluted share reduction more than 1.5x FSLR's 1.00%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
83.55%
OCF growth under 50% of FSLR's 446.46%. Michael Burry might suspect questionable revenue recognition or rising costs.
54.77%
FCF growth under 50% of FSLR's 277.65%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
15.45%
10Y revenue/share CAGR under 50% of FSLR's 395.33%. Michael Burry would suspect a lasting competitive disadvantage.
-36.17%
Negative 5Y CAGR while FSLR stands at 7.91%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-31.06%
Negative 3Y CAGR while FSLR stands at 17.28%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-6.52%
Negative 10Y OCF/share CAGR while FSLR stands at 420.62%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
28.49%
Below 50% of FSLR's 2070.24%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
22.80%
3Y OCF/share CAGR under 50% of FSLR's 1281.51%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-458.30%
Negative 10Y net income/share CAGR while FSLR is at 223.83%. Joel Greenblatt sees a major red flag in long-term profit erosion.
4.71%
Below 50% of FSLR's 94.94%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-259.26%
Negative 3Y CAGR while FSLR is 123.25%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-53.50%
Negative equity/share CAGR over 10 years while FSLR stands at 307.21%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-46.51%
Negative 5Y equity/share growth while FSLR is at 32.78%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-52.35%
Negative 3Y equity/share growth while FSLR is at 10.34%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.82%
AR growth is negative/stable vs. FSLR's 26.69%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-8.26%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.10%
Negative asset growth while FSLR invests at 5.60%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.89%
We have a declining book value while FSLR shows 4.08%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
18.11%
Debt growth far above FSLR's 5.78%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.75%
We increase R&D while FSLR cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-0.44%
We cut SG&A while FSLR invests at 3.25%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.